Whitney & Co’s Celgene Corp CELG Stock Holding History

Whitney & Co’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-288	Closed	-$26K	–	349
2018 Q1	$26K	Buy	+288	New	+$27.6K	0.01%	201

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Whitney & Co's CELG Position: Q2 2018 in Review

Whitney & Co sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 288 shares — an estimated $26K sold.

Whitney & Co first reported a position in CELG in Q1 2018 and held it in 1 quarter. The position peaked at $26K in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Whitney & Co reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Whitney & Co sold 288 Celgene Corp shares in Q2 2018, an estimated $26K.
Whitney & Co first reported a position in Celgene Corp in Q1 2018 and held it in 1 quarter.
Whitney & Co's Celgene Corp position peaked at $26K in Q1 2018.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Whitney & Co's 13F filing for Q2 2018, filed 14 Aug 2018.